The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
Open accessAbstract
The Epstein-Barr virus (EBV)-encoded nuclear antigen EBNA1 is critical for the persistence of the viral episome in replicating EBV-transformed human B cells. Therefore, all EBV-induced tumors express this foreign antigen. However, EBNA1 is invisible to CD8+ cytotoxic T lymphocytes because its Gly/Ala repeat domain prevents proteasome-dependent processing for presentation on major histocompatibility complex (MHC) class I. We now describe that CD4+ T cells from healthy adults are primed to EBNA1. In fact, among latent EBV antigens that stimulate CD4+ T cells, EBNA1 is preferentially recognized. We present evidence that the CD4+ response may provide a protective role, including interferon γ secretion and direct cytolysis after encounter of transformed B lymphocyte cell lines (B-LCLs). Dendritic cells (DCs) process EBNA1 from purified protein and from MHC class II–mismatched, EBNA1-expressing cells including B-LCLs. In contrast, B-LCLs and Burkitt's lymphoma lines likely present EBNA1 after endogenous processing, as their capacity to cross-present from exogenous sources is weak or undetectable. By limiting dilution, there is a tight correlation between the capacity of CD4+ T cell lines to recognize autologous B-LCL–expressing EBNA1 and DCs that have captured EBNA1. Therefore, CD4+ T cells can respond to the EBNA1 protein that is crucial for EBV persistence. We suggest that this immune response is initiated in vivo by DCs that present EBV-infected B cells, and that EBNA1-specific CD4+ T cell immunity be enhanced to prevent and treat EBV-associated malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Self-citationSallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Self-citationT-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,292
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Two populations of Ia-like molecules on a human B cell line.
Lampson, L. A., & Levy, R. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.1.293 · Cited by 1,095
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Self-citationHUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747
Bender, A., Sapp, M., Schuler, G., Steinman, R. M., & Bhardwaj, N. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00079-8 · Cited by 663
Self-citationThe Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A., & Masucci, M. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12616 · Cited by 562
Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis
Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J., & Rickinson, A. B. (1991) · Nature · doi:10.1038/349612a0 · Cited by 506
Cardin, R. D., Brooks, J. W., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.863 · Cited by 501
Kilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses
Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., & Kikutani, H. (1999) · Science · doi:10.1126/science.286.5438.300 · Cited by 437
Wang, D., Liebowitz, D., Wang, F., Gregory, C. D., Rickinson, A. B., Larson, R. A., Springer, T. A., & Kieff, E. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4173-4184.1988 · Cited by 384
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion
Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M., & Bhardwaj, N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6762 · Cited by 365
Self-citationThree pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes
Rowe, M., Lear, A. L., Croom-Carter, D., Davies, A. H., & Rickinson, A. B. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.122-131.1992 · Cited by 351
Latent membrane protein 1of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
Gires, O. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3064 · Cited by 350
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Kieser, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6478 · Cited by 319
Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., & Friedman, S. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1557 · Cited by 278
Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P., Kurilla, M. G., Frappier, L., & Rickinson, A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80397-0 · Cited by 261
Self-citationEpstein-Barr virus strategy in normal and neoplastic B cells
Klein, G. (1994) · Cell · doi:10.1016/0092-8674(94)90125-2 · Cited by 244
Gorga, J. C., Horejsí, V, Johnson, D. R., Raghupathy, R., & Strominger, J. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47699-5 · Cited by 219
Bochkarev, A., Barwell, J. A., Pfuetzner, R. A., Bochkareva, E., Frappier, L., & Edwards, A. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81056-9 · Cited by 214
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5602-5612.1994 · Cited by 200
Khanna, R., Burrows, S. R., Nicholls, J., & Poulsen, L. M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<451::aid-immu451>3.0.co;2-u · Cited by 178
Kaye, K. M., Izumi, K. M., Mosialos, G., & Kieff, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.675-683.1995 · Cited by 173
Steven, N. M., Leese, A. M., Annels, N. E., Lee, S. P., & Rickinson, A. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1801 · Cited by 168
Aversa, G., Chang, C., Carballido, J. M., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4036 · Cited by 165
Frappier, L., & O’Donnell, M. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89523-4 · Cited by 151
Self-citationSharipo, A., Imreh, M. P., Leonchiks, A., Imreh, S., & Masucci, M. G. (1998) · Nature Medicine · doi:10.1038/nm0898-939 · Cited by 148
Watkins, D. I., Chen, Z. W., Hughes, A. L., Evans, M. G., Tedder, T. F., & Letvin, N. L. (1990) · Nature · doi:10.1038/346060a0 · Cited by 147
Kieser, A., Kaiser, C., & Hammerschmidt, W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2511 · Cited by 144
Castro, A. G., Hauser, T. M., Cocks, B. G., Abrams, J. S., Zurawski, S., Churakova, T., Zonin, F., Robinson, D. S., Tangye, S. G., Aversa, G., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5860 · Cited by 138
CD4 + T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ
Christensen, J. P., Cardin, R. D., Branum, K. C., & Doherty, P. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5135 · Cited by 123
Khanna, R., Burrows, S. R., Thomson, S. A., Moss, D. J., Cresswell, P., Poulsen, L. M., & Cooper, L. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3619 · Cited by 96
EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin
Frappier, L., & O’Donnell, M. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1786-1790.1992 · Cited by 91
Self-citationSubklewe, M. S., Chahroudi, A., Schmaljohn, A. L., Kurilla, M. G., Bhardwaj, N., & Steinman, R. M. (1999) · Blood · doi:10.1182/blood.v94.4.1372 · Cited by 75
Self-citationLee, S. P., Thomas, W. A., BLAKE, N. W., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260831 · Cited by 64
Friede, T., Gnau, V., Jung, G., Keilholz, W., Stevanović, S., & Rammensee, H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00010-5 · Cited by 62
Khanna, R. (1997) · International Immunology · doi:10.1093/intimm/9.10.1537 · Cited by 60
Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus
Zhang, D., Frappier, L., Gibbs, E., Hurwitz, J., & O’Donnell, M. E. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.2.631 · Cited by 55
Self-citationTaswell, C., MacDonald, H. R., & Cerottini, J. C. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.151.6.1372 · Cited by 55
Cited by
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Self-citationEndogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy
Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T., & Münz, C. (2005) · Science · doi:10.1126/science.1104904 · Cited by 860
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R. M., & Inaba, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020161 · Cited by 648
Self-citation
Metadata
- Authors
- Münz, C., Bickham, K. L., Subklewe, M., Tsang, M. L., Chahroudi, A., Kurilla, M. G., Zhang, D., O'Donnell, M., & Steinman, R. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-05-08
- Volume
- 191
- Issue
- 10
- Pages
- 1649-1660
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2150071886
- Cited by
- 349
- References
- 57
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.